Title : Development of new poly(ADP-ribose) polymerase (PARP) inhibitors in ovarian cancer: Quo Vadis?

Pub. Date : 2020 Dec

PMID : 33490218






1 Functional Relationships(s)
Download
Sentence
Compound Name
Protein Name
Organism
1 Finally, since October 2018 talazoparib is FDA and EMA approved for BRCA carriers with metastatic breast cancers. talazoparib BRCA1 DNA repair associated Homo sapiens